Showing results (1-10 of 313) with videos related to
Sort By:
Pageof 32
Med (New York, N.Y.)|May 19, 2022
PLSec: A novel, liquid biomarker for HCC riskJoseph W Franses, Irun Bhan, Andrew X ZhuClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2022
Neoadjuvant Approaches in Hepatocellular Carcinoma: There's No Time Like the PresentJoseph W Franses, Andrew X ZhuCancer Research|December 7, 2011
The evolution of endothelial regulatory paradigms in cancer biology and vascular repairJoseph W Franses, Elazer R EdelmanMolecular Cell|May 13, 2008
Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damageEric Batchelor, Caroline S Mock, Irun Bhan, et al.Hepatology Communications|September 27, 2024
HCC spatial transcriptomic profiling reveals significant and potentially targetable cancer-endothelial interactionsChenyue Lu, Amaya Pankaj, Michael Raabe, et al.Frontiers in Oncology|September 13, 2024
Targeted therapies in hepatocellular carcinoma: past, present, and futureRushabh Gujarathi, Joseph W Franses, Anjana Pillai, et al.JAMA Surgery|September 4, 2024
Sex and Size Disparities in Access to Liver Transplant for Patients With Hepatocellular CarcinomaDavid C Cron, Rafal D Mazur, Irun Bhan, et al.Science Translational Medicine|January 21, 2011
Stromal endothelial cells directly influence cancer progressionJoseph W Franses, Aaron B Baker, Vipul C Chitalia, et al.Cancer|November 28, 2007
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinomaAndrew X ZhuBMC Medicine|August 26, 2009
Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?Andrew X ZhuPageof 32